Variation in omeprazole pharmacokinetics in a random Iranian population: a pilot study-Reference-Cited by-同舟云学术

Variation in omeprazole pharmacokinetics in a random Iranian population: a pilot study

Published:2012-09 Issue:6 Volume:33 Page:324-331
ISSN:0142-2782
Container-title:Biopharmaceutics & Drug Disposition
language:en
Short-container-title:Biopharm. Drug Dispos.

Author:

Noubarani Maryam¹,Kobarfard Farzad,Motevalian Manijeh²,Keyhanfar Fariborz²

Affiliation:

1. Department of Pharmacology and Toxicology, Faculty of Pharmacy; Zanjan University of Medical Sciences; Zanjan; Iran

2. Department of Pharmacology, Faculty of Medicine; Tehran University of Medical Sciences; Tehran; Iran

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/bdd.1805/fullpdf

Reference32 articles.

1. Pharmacology of proton pump inhibitors;Shin;Curr Gastroenterol Rep,2008

2. Predictability of the effects of race or ethnicity on pharmacokinetics of drugs;Johnson;Int J Clin Pharmacol Ther,2000

3. Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms;Kim;J Clin Pharmacol,2004

4. Guidance on ethnic factors in the acceptability of foreign clinical data;International Conference on Harmonization Steering Committee;Fed Regist,1998

5. Pharmacogenetics of the proton pump inhibitors: a systematic review;Chong;Pharmacotherapy,2003

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proton pump inhibitors in Iranian population: from clinical regimens to pharmacogenomics;Physiology and Pharmacology;2020-06-15

2. Urine metabolic ratio of omeprazole in relation to CYP2C19 polymorphisms in Russian peptic ulcer patients;Pharmacogenomics and Personalized Medicine;2017-09